Physician profile
Benjamin T Bjerke
NPI 1639496292
$7,311.57
in general payments reported to CMS, 2019-2025
23 companies · $2,038 in 2025
The $2,038 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,209 · 2020: $228 · 2021: $345 · 2022: $1,490 · 2023: $1,075 · 2024: $927 · 2025: $2,038.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,359 · Travel and Lodging: $681.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,359.42 |
| Travel and Lodging | $680.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,179.22 | 2022-2025 | Cd Horizon Spinal System, Anteralign Spinal System With Titan Nanolock Surface Technology, Catalyft Pl Expandable Interbody System |
| Globus Medical, INC. | $1,284.16 | 2021-2025 | Adira, Fortify, Sable |
| Nuvasive, INC. | $1,158.77 | 2019-2021 | |
| Depuy Synthes Sales INC. | $359.06 | 2020-2024 | Synfix Evolution, Viper, Vivigen Mis Delivery System |
| Medical Device Business Services, INC. | $217.00 | 2021 | |
| Ferring Pharmaceuticals INC. | $165.26 | 2023-2025 | Euflexxa |
| Stryker Corporation | $150.00 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $105.78 | 2023 | Exparel, Zilretta, Iovera |
| Encore Medical, LP | $102.30 | 2022 | |
| Sanara Medtech INC. | $95.26 | 2022-2023 | Celleraterx |
| Sanofi-Aventis U.S. LLC | $78.79 | 2023 | |
| Abbott Laboratories | $75.11 | 2019 | |
| Spinal Elements, INC. | $55.03 | 2023 | |
| Expanding Innovations, INC. | $48.72 | 2025 | X-Pac |
| Providence Medical Technology, INC. | $39.88 | 2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $38.84 | 2022-2023 | Prolia, Evenity |
| Avanos Medical | $38.68 | 2023 | Trivisc Sodium Hyaluronate, On-Q* Pump and Accessories |
| Alpha Orthopedic Systems | $30.73 | 2022-2023 | |
| Zimmer Biomet Holdings, INC. | $27.52 | 2023 | Gel-One Cross-Linked Hyaluronate |
| Nevro Corp. | $19.59 | 2021 | |
| Pacira Therapeutics, INC. | $16.47 | 2019 | |
| Boston Scientific Corporation | $13.45 | 2019 | |
| Si-Bone, INC. | $11.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Bjerke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.